Rybelsus is approved as a type 2 diabetes tablet, not as a dedicated weight-loss drug
In contrast, semaglutide, despite its widespread clinical use for glycemic control and weight loss, showed minimal interaction with neurodegenerative pathways within the DM2-AD comorbidity network, suggesting that its metabolic benefits may not translate into AD risk reduction through core disease-associated mechanisms
Moreover, more importantly, the mitotic count was up to 2 /10HPFs, which may have been a factor attributing to the lung metastasis
It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk. Wegovy, made by Novo Nordisk, has been hailed as a miracle for its ability to suppress a persons appetite
It can also help lower the risk of cardiovascular death from heart attacks, strokes, or heart failure in adults with heart disease or heart failure
Gradual Increases : Doses are adjusted over weeks based on individual tolerance and progress, under medical supervision
